Form 8-K - Current report:
SEC Accession No. 0000950103-25-007390
Filing Date
2025-06-13
Accepted
2025-06-13 15:01:28
Documents
13
Period of Report
2025-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp230162_8k.htm   iXBRL 8-K 51932
5 EXHIBIT 99.1 dp230162_ex9901.htm EX-99.1 24853
  Complete submission text file 0000950103-25-007390.txt   246048

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ndoi-20250613.xsd EX-101.SCH 3002
3 XBRL LABEL FILE ndoi-20250613_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE ndoi-20250613_pre.xml EX-101.PRE 22350
16 EXTRACTED XBRL INSTANCE DOCUMENT dp230162_8k_htm.xml XML 3098
Mailing Address 9 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 9 GREAT VALLEY PARKWAY MALVERN PA 19355 (484) 216-0000
Endo, Inc. (Filer) CIK: 0002008861 (see all company filings)

EIN.: 301390281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-280767 | Film No.: 251046061
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)